Clinical Services
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
771
NCT00286845
Use of the MiCK Assay for Apoptosis in AML
Phase: N/A
Role: Lead Sponsor
Start: Jan 31, 2006
Completion: Dec 31, 2009
NCT00443196
Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas
Phase: Phase 2/3
Start: Mar 31, 2006
Completion: Sep 30, 2010
NCT00243685
Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis
Start: Sep 30, 2006
Completion: May 31, 2009
NCT00901264
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Start: Dec 31, 2008
Completion: Nov 30, 2012
NCT01770665
Validation of the MiCK Assay
Start: Jun 30, 2012
Completion: Sep 30, 2016
NCT02137811
Demographics, Clinical Outcomes, and Physician Attitudes in Patients Who Have Received The MiCK Assay (CorrectChemo)
Start: Apr 30, 2014
Completion: Jun 30, 2016
NCT06844136
ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients
Start: Nov 22, 2023
Completion: Jul 31, 2027
Loading map...